Methods for the preparation of HCV polymerase inhibitors

Details for Australian Patent Application No. 2006283297 (hide)

Owner Pfizer Inc.

Inventors Tucker, John Lloyd; Matthews, Christopher Frederick; Scott, Robert William

Agent Shelston IP

Pub. Number AU-B-2006283297

PCT Pub. Number WO2007/023381

Priority 60/711,042 24.08.05 US; 60/744,273 04.04.06 US; 60/804,644 13.06.06 US

Filing date 16 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 26 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 213/55 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/023381 Priority application(s): WO2007/023381

26 July 2012 Application Accepted

  Published as AU-B-2006283297

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283299-Optical component with cells

2006283294-Method for signaling a device to perform no synchronization or include a syncronization delay on multimedia streams